SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists

Bioorg Med Chem Lett. 2007 Jan 1;17(1):189-92. doi: 10.1016/j.bmcl.2006.09.060. Epub 2006 Oct 5.

Abstract

We previously disclosed that 6-aryl benzoxazin-2-ones were PR modulators. In a continuation of this work we examined the SAR of new 6-arylamino benzoxazinones and found the targets 1-25, with an extra amino linker between the pendent 6-aryl groups and benzoxazinone or benzoxazine-2-thione core, were PR antagonists. A series of compounds with substituents at the 1- and 4-positions as well as different 6-aryl groups were prepared and tested in the T47D cell alkaline phosphatase assay. Interestingly, the SAR unveiled from the 6-arylamino benzoxazinones was quite different from those of their parent compounds. For example, in contrast to the 6-aryl benzoxazinones, methyl substitution at the 1-position significantly increased the potency of 6-arylamino benzoxazinones. Several 6-arylamino benzoxazinones (e.g., 12, IC(50)=5.0 nM) had low nanomolar in vitro potency as PR antagonists in the T47D cell alkaline phosphatase assay.

MeSH terms

  • Benzoxazines / chemistry*
  • Benzoxazines / pharmacology*
  • Cell Line, Tumor
  • Contraceptive Agents, Female / chemistry*
  • Contraceptive Agents, Female / pharmacology*
  • Humans
  • Inhibitory Concentration 50
  • Receptors, Progesterone / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Benzoxazines
  • Contraceptive Agents, Female
  • Receptors, Progesterone